Cardiology

Blood test for heart attack may be sold

Published in Vaccine Weekly, February 18th, 2004

The Cleveland Clinic has received $6 million from an Arkansas company to help develop and sell diagnostic tests, including a blood test that could determine if someone is at risk for having a heart attack.

The clinic on January 19, 2004, announced the investment by ExOxEmis of Little Rock, Ark.

The company also will develop tests to help diagnose asthma and similar diseases, said Eric Topol, chief academic officer and chairman of the department of cardiovascular medicine.

"The development of such tests will help physicians determine more quickly and accurately the diagnosis of patients with inflammatory diseases, such as asthma...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2004-02-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry